Ana Barreira Díaz (Ana Barreira-Diaz, Ana Barreira-Díaz)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 22

Top Topics

Hepatitis B Virus

Fine Needle Aspiration

Rheumatoid Arthritis Patients

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Hepatology (Baltimore, Md.)

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Mar Riveiro, Ana Barreira Díaz, María-Teresa Salcedo, Ana Callejo-Pérez, Eva Muñoz-Couselo, Patricia Iranzo, Carolina Ortiz-Velez, Susana Cedrés, Nely Díaz-Mejía, Juan-Carlos Ruiz-Cobo, Rafael Morales, Juan Aguilar-Company, Ester Zamora, Mafalda Oliveira, María-Teresa Sanz-Martínez, Lluis Viladomiu, Mónica Martínez-Gallo, Enriqueta Felip, María Buti
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury. Alimentary pharmacology & therapeutics (2024)
Mar Riveiro, Ana Barreira Díaz, Paula Esteban, Rosa Rota, Carmen Álvarez-Navascúes, Indhira Pérez-Medrano, Beatriz Mateos, Elena Gómez, Gema De-la-Cruz, Carlos Ferre, Diana Horta, Álvaro Díaz-González, Javier Ampuero, Fernando Díaz-Fontenla, Magdalena Salcedo, Juan-Carlos Ruiz-Cobo, María Carlota Londoño
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry. Liver international : official journal of the International Association for the Study of the Liver (2024)
Mar Riveiro, Ana Barreira Díaz, Paula Esteban, Rosa Rota, Carmen Álvarez-Navascúes, Indhira Pérez-Medrano, Beatriz Mateos, Elena Gómez, Gema De-la-Cruz, Carlos Ferre, Diana Horta, Álvaro Díaz-González, Javier Ampuero, Fernando Díaz-Fontenla, Magdalena Salcedo, Juan-Carlos Ruiz-Cobo, María Carlota Londoño
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry. Liver international : official journal of the International Association for the Study of the Liver 44 (9) (2024)
Mar Riveiro, Ana Barreira Díaz, María-Teresa Salcedo, Ana Callejo-Pérez, Eva Muñoz-Couselo, Patricia Iranzo, Carolina Ortiz-Velez, Susana Cedrés, Nely Díaz-Mejía, Juan-Carlos Ruiz-Cobo, Rafael Morales, Juan Aguilar-Company, Ester Zamora, Mafalda Oliveira, María-Teresa Sanz-Martínez, Lluis Viladomiu, Mónica Martínez-Gallo, Enriqueta Felip, María Buti
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury. Alimentary pharmacology & therapeutics 59 (7) (2024)
Mar Riveiro, Ana Barreira Díaz, María-Teresa Salcedo, Ana Callejo-Pérez, Eva Muñoz-Couselo, Patricia Iranzo, Carolina Ortiz-Velez, Susana Cedrés, Nely Díaz-Mejía, Juan-Carlos Ruiz-Cobo, Rafael Morales, Juan Aguilar-Company, Ester Zamora, Mafalda Oliveira, María-Teresa Sanz-Martínez, Lluis Viladomiu, Mónica Martínez-Gallo, Enriqueta Felip, María Buti
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury. Alimentary pharmacology & therapeutics 59 (7) (2024)
Mar Riveiro, Ana Barreira Díaz, Paula Esteban, Rosa Rota, Carmen Álvarez-Navascúes, Indhira Pérez-Medrano, Beatriz Mateos, Elena Gómez, Gema De-la-Cruz, Carlos Ferre, Diana Horta, Álvaro Díaz-González, Javier Ampuero, Fernando Díaz-Fontenla, Magdalena Salcedo, Juan-Carlos Ruiz-Cobo, María Carlota Londoño
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry. Liver international : official journal of the International Association for the Study of the Liver 44 (9) (2024)
Mar Riveiro, Ana Barreira Díaz, María-Teresa Salcedo, Ana Callejo-Pérez, Eva Muñoz-Couselo, Patricia Iranzo, Carolina Ortiz-Velez, Susana Cedrés, Nely Díaz-Mejía, Juan-Carlos Ruiz-Cobo, Rafael Morales, Juan Aguilar-Company, Ester Zamora, Mafalda Oliveira, María-Teresa Sanz-Martínez, Lluis Viladomiu, Mónica Martínez-Gallo, Enriqueta Felip, María Buti
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury. Alimentary pharmacology & therapeutics 59 (7) (2024)
Álvaro Díaz-González, Manuel Hernández Guerra, Indhira Pérez-Medrano, Víctor Sapena, Mar Riveiro, Ana Barreira Díaz, Elena Gómez, Rosa María Morillas, María Del Barrio, Laia Escudé, Beatriz Mateos, Diana Horta, Judith Gómez, Isabel Conde Amiel, Carlos Ferre, Ismael El Hajra, Ana Arencibía, Javier Manuel Zamora-Olaya, Ahinoa Fernández Moreno, Magdalena Salcedo Plaza, Esther Molina, Anna Soria, Pamela Estévez, Carmen López, Montserrat García-Retortillo, Javier Crespo, María Carlota Londoño, null null
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration. Hepatology (Baltimore, Md.) 77 (4) (2023)
Álvaro Díaz-González, Manuel Hernández Guerra, Indhira Pérez-Medrano, Víctor Sapena, Mar Riveiro, Ana Barreira Díaz, Elena Gómez, Rosa María Morillas, María Del Barrio, Laia Escudé, Beatriz Mateos, Diana Horta, Judith Gómez, Isabel Conde Amiel, Carlos Ferre, Ismael El Hajra, Ana Arencibía, Javier Manuel Zamora-Olaya, Ahinoa Fernández Moreno, Magdalena Salcedo Plaza, Esther Molina, Anna Soria, Pamela Estévez, Carmen López, Montserrat García-Retortillo, Javier Crespo, María Carlota Londoño, null null
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration. Hepatology (Baltimore, Md.) (2023)
Anna Feliu-Prius, Ana Barreira Díaz, Ariadna Rando, Elena Vargas-Accarino, Adriana Palom, Judit Vico-Romero, Juan-Carlos Ruiz-Cobo, Mar Riveiro-Barciela, Francisco Rodriguez-Frías, Rafael Esteban, Maria Buti
Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study. Liver international : official journal of the International Association for the Study of the Liver (2023)
Álvaro Díaz-González, Manuel Hernández Guerra, Indhira Pérez-Medrano, Víctor Sapena, Mar Riveiro, Ana Barreira Díaz, Elena Gómez, Rosa María Morillas, María Del Barrio, Laia Escudé, Beatriz Mateos, Diana Horta, Judith Gómez, Isabel Conde Amiel, Carlos Ferre, Ismael El Hajra, Ana Arencibía, Javier Manuel Zamora-Olaya, Ahinoa Fernández Moreno, Magdalena Salcedo Plaza, Esther Molina, Anna Soria, Pamela Estévez, Carmen López, Montserrat García-Retortillo, Javier Crespo, María Carlota Londoño, null null
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration. Hepatology (Baltimore, Md.) (2023)
Álvaro Díaz-González, Manuel Hernández Guerra, Indhira Pérez-Medrano, Víctor Sapena, Mar Riveiro, Ana Barreira Díaz, Elena Gómez, Rosa María Morillas, María Del Barrio, Laia Escudé, Beatriz Mateos, Diana Horta, Judith Gómez, Isabel Conde Amiel, Carlos Ferre, Ismael El Hajra, Ana Arencibía, Javier Manuel Zamora-Olaya, Ahinoa Fernández Moreno, Magdalena Salcedo Plaza, Esther Molina, Anna Soria, Pamela Estévez, Carmen López, Montserrat García-Retortillo, Javier Crespo, María Carlota Londoño, null null
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration. Hepatology (Baltimore, Md.) 77 (4) (2023)
Anna Feliu-Prius, Ana Barreira Díaz, Ariadna Rando, Elena Vargas-Accarino, Adriana Palom, Judit Vico-Romero, Juan-Carlos Ruiz-Cobo, Mar Riveiro-Barciela, Francisco Rodriguez-Frías, Rafael Esteban, Maria Buti
Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study. Liver international : official journal of the International Association for the Study of the Liver 44 (3) (2023)
Álvaro Díaz-González, Manuel Hernández Guerra, Indhira Pérez-Medrano, Víctor Sapena, Mar Riveiro, Ana Barreira Díaz, Elena Gómez, Rosa María Morillas, María Del Barrio, Laia Escudé, Beatriz Mateos, Diana Horta, Judith Gómez, Isabel Conde Amiel, Carlos Ferre, Ismael El Hajra, Ana Arencibía, Javier Manuel Zamora-Olaya, Ahinoa Fernández Moreno, Magdalena Salcedo Plaza, Esther Molina, Anna Soria, Pamela Estévez, Carmen López, Montserrat García-Retortillo, Javier Crespo, María Carlota Londoño, null null
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration. Hepatology (Baltimore, Md.) 77 (4) (2023)
Anna Feliu-Prius, Ana Barreira Díaz, Ariadna Rando, Elena Vargas-Accarino, Adriana Palom, Judit Vico-Romero, Juan-Carlos Ruiz-Cobo, Mar Riveiro-Barciela, Francisco Rodriguez-Frías, Rafael Esteban, Maria Buti
Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study. Liver international : official journal of the International Association for the Study of the Liver 44 (3) (2023)
Ana Barreira Díaz, Ariadna Rando, Anna Feliu-Prius, Adriana Palom, Francisco Rodríguez-Frías, Elena Vargas-Accarino, Judit Vico-Romero, Nieves Palomo, Mar Riveiro-Barciela, Rafael Esteban, Maria Buti
LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of Barcelona. BMJ open 12 (12) (2022)
Mar Riveiro, Maria José Soler, Ana Barreira Díaz, Sheila Bermejo, Sebastian Bruera, Maria E Suarez-Almazor
Expert Clinical Management of Severe Immune-Related Adverse Events: Results from a Multicenter Survey on Hot Topics for Management. Journal of clinical medicine 11 (20) (2022)
Ana Barreira Díaz, Ariadna Rando, Anna Feliu-Prius, Adriana Palom, Francisco Rodríguez-Frías, Elena Vargas-Accarino, Judit Vico-Romero, Nieves Palomo, Mar Riveiro-Barciela, Rafael Esteban, Maria Buti
LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of Barcelona. BMJ open 12 (12) (2022)
Ana Barreira Díaz, Ariadna Rando, Anna Feliu-Prius, Adriana Palom, Francisco Rodríguez-Frías, Elena Vargas-Accarino, Judit Vico-Romero, Nieves Palomo, Mar Riveiro-Barciela, Rafael Esteban, Maria Buti
LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of Barcelona. BMJ open 12 (12) (2022)
Ana Barreira Díaz, Ariadna Rando, Anna Feliu-Prius, Adriana Palom, Francisco Rodríguez-Frías, Elena Vargas-Accarino, Judit Vico-Romero, Nieves Palomo, Mar Riveiro-Barciela, Rafael Esteban, Maria Buti
LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of Barcelona. BMJ open 12 (12) (2022)
Ana Barreira Díaz, Ariadna Rando, Anna Feliu-Prius, Adriana Palom, Francisco Rodríguez-Frías, Elena Vargas-Accarino, Judit Vico-Romero, Nieves Palomo, Mar Riveiro-Barciela, Rafael Esteban, Maria Buti
LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of Barcelona. BMJ open 12 (12) (2022)
Ana Barreira Díaz, Ariadna Rando, Anna Feliu-Prius, Adriana Palom, Francisco Rodríguez-Frías, Elena Vargas-Accarino, Judit Vico-Romero, Nieves Palomo, Mar Riveiro-Barciela, Rafael Esteban, Maria Buti
LINK-B: study protocol of a retrospective and prospective project for identification and linkage to care of people living with hepatitis B in a large health area of Barcelona. BMJ open 12 (12) (2022)